DBV Technologies (ADR)
Develops an investigational skin patch for peanut allergy using epicutaneous immunotherapy.
$13.72
After-hours close+0.20 (+1.48%)
At close$13.52(−6.18%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$0.16 | — | — |
| Jul 2026 | −$0.12 | −$0.14 | −14.4% |
| Apr 2026 | −$0.14 | −$0.56 | −300.0% |
| Mar 2026 | −$1.30 | −$1.15 | +11.5% |
| Oct 2025 | −$1.45 | −$1.20 | +17.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Oct 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Jan 2020 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Mar 2019 | |||
| Oct 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Mar 2018 | |||
| Jul 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Mar 2017 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Apr 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | −$0.16 | — | — | $664.0K | — | — |
| Jul 16, 2026 | −$0.12 | −$0.14 | −14.4% | $778.2K | $800.8K | +2.9% |
| Apr 30, 2026 | −$0.14 | −$0.56 | −300.0% | $1.1M | $1.1M | −4.9% |
| Mar 27, 2026 | −$1.30 | −$1.15 | +11.5% | $1.5M | $574.6K | −60.5% |
| Oct 28, 2025 | −$1.45 | −$1.20 | +17.2% | $1.1M | $3.2M | +204.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 29, 2025 | ||||||
| Apr 30, 2025 | ||||||
| Mar 27, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Jul 30, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Oct 31, 2023 | ||||||
| Jul 31, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 2, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 1, 2022 | ||||||
| May 2, 2022 | ||||||
| Mar 3, 2022 | ||||||
| Oct 26, 2021 | ||||||
| Aug 2, 2021 | ||||||
| May 3, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Oct 30, 2020 | ||||||
| Jul 31, 2020 | ||||||
| Apr 30, 2020 | ||||||
| Mar 4, 2020 | ||||||
| Jan 29, 2020 | ||||||
| Aug 1, 2019 | ||||||
| Apr 30, 2019 | ||||||
| Mar 5, 2019 | ||||||
| Oct 30, 2018 | ||||||
| Sep 7, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 16, 2018 | ||||||
| Mar 14, 2018 | ||||||
| Jul 28, 2017 | ||||||
| Jun 30, 2017 | ||||||
| Mar 22, 2017 | ||||||
| Mar 15, 2017 | ||||||
| Jul 29, 2016 | ||||||
| Apr 30, 2016 | ||||||
| Apr 11, 2016 | ||||||
| Nov 3, 2015 | ||||||
| Jul 27, 2015 | ||||||